MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about analyst meet

03 Feb 2026 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that an analyst meeting is scheduled on 9th February 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.05
Dr. Reddys Labs. 1145.25
Cipla 1359.25
Lupin 2050.95
Zydus Lifesciences 1108.25
View more..